Shopping Cart
- Remove All
- Your shopping cart is currently empty
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $257 | In Stock | |
5 mg | $638 | In Stock | |
10 mg | $912 | In Stock | |
25 mg | $1,370 | In Stock | |
50 mg | $1,850 | In Stock |
Description | MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury. |
Molecular Weight | 270.32 |
Formula | C17H18O3 |
Cas No. | 1895957-18-2 |
Smiles | C(=C/CC1=CC=C(OC)C=C1)\C2=CC(OC)=C(O)C=C2 |
Relative Density. | 1.137 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | 5% DMSO+40% PEG300+5% Tween 80+50% Saline: 2.5 mg/mL (9.25 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. Ethanol: 27.03 mg/mL (100 mM), Sonication is recommended. DMSO: 50 mg/mL (184.9 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
Ethanol/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.